These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20011710)

  • 1. Exploring the role of Chlamydia pneumoniae in cardiovascular disease: a narrative review.
    Vainas T; Sayed S; Bruggeman CA; Stassen FR
    Drugs Today (Barc); 2009 Nov; 45 Suppl B():165-72. PubMed ID: 20011710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives.
    Sessa R; Nicoletti M; Di Pietro M; Schiavoni G; Santino I; Zagaglia C; Del Piano M; Cipriani P
    Int J Immunopathol Pharmacol; 2009; 22(1):9-14. PubMed ID: 19309547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Chlamydia pneumoniae in atherosclerosis.
    Watson C; Alp NJ
    Clin Sci (Lond); 2008 Apr; 114(8):509-31. PubMed ID: 18336368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chlamydia pneumoniae, atherosclerosis, and coronary disease].
    Monno R; Di Biase M; Costi A; de Nicolò T; Correale M; Bolognese P; Losacco G
    Ital Heart J Suppl; 2003 May; 4(5):383-97. PubMed ID: 12848076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia pneumoniae and atherosclerosis.
    Grayston JT
    Clin Infect Dis; 2005 Apr; 40(8):1131-2. PubMed ID: 15791512
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials.
    Campbell LA; Rosenfeld ME
    Front Cell Infect Microbiol; 2014; 4():34. PubMed ID: 24711989
    [No Abstract]   [Full Text] [Related]  

  • 7. [Investigation of Chlamydophila pneumoniae seropositivity and risk factors in patients with atherosclerotic vascular disease in Sivas, Turkey].
    Kılıç ZB; Poyraz O; Kılıç AT
    Mikrobiyol Bul; 2012 Jan; 46(1):156-8. PubMed ID: 22399186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia pneumoniae infection related atherosclerotic clinical variables on carotid stenosis.
    Colpan ME; Attar A; Colpan A; Karahan C; Seckin S; Sargon MF; Egemen N
    J Clin Neurosci; 2004 May; 11(4):389-94. PubMed ID: 15080954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease.
    Dugan JP; Feuge RR; Burgess DS
    Clin Ther; 2002 May; 24(5):719-35. PubMed ID: 12075941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials.
    Higgins JP
    Mayo Clin Proc; 2003 Mar; 78(3):321-32. PubMed ID: 12630585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.
    Wszola M; Kwiatkowski A; Nosek R; Podsiadly E; Meszaros J; Danielewicz R; Lisik W; Ostrowski K; Chmura A; Adadyński L; Paczek L; Durlik M; Tylewska-Wierzbanowska S; Rowiński W
    Transplant Proc; 2006; 38(1):31-4. PubMed ID: 16504656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.
    Rothstein NM; Quinn TC; Madico G; Gaydos CA; Lowenstein CJ
    J Infect Dis; 2001 Jan; 183(2):232-238. PubMed ID: 11120929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic therapy for coronary heart disease: the myth and the reality.
    Kuppuswamy VC; Gupta S
    Timely Top Med Cardiovasc Dis; 2006 Jan; 10():E2. PubMed ID: 16404482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Chlamydia pneumoniae a risk factor for peripheral atherosclerosis?
    Ustünsoy H; Sivrikoz C; Sirmatel F; Bakir K; Burma O; Kazaz H
    Asian Cardiovasc Thorac Ann; 2007 Jan; 15(1):9-13. PubMed ID: 17244915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-Analysis.
    Filardo S; Di Pietro M; Farcomeni A; Schiavoni G; Sessa R
    Mediators Inflamm; 2015; 2015():378658. PubMed ID: 26346892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?
    Campbell LA; Kuo CC
    Nat Rev Microbiol; 2004 Jan; 2(1):23-32. PubMed ID: 15035006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia pneumoniae, antibiotic treatment, and early atherosclerosis.
    Liuba P; Pesonen E; Paakkari I
    Circulation; 2003 Jun; 107(22):e205; author reply e205. PubMed ID: 12796417
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of strong association of Chlamydia pneumoniae and atherosclerosis in a Jordanian population.
    Al-Younes HM; Abu Abeeleh MA; Jaber BM
    J Infect Dev Ctries; 2016 May; 10(5):457-64. PubMed ID: 27249520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy.
    Sawayama Y; Okada K; Maeda S; Ohnishi H; Furusyo N; Hayashi J
    Fukuoka Igaku Zasshi; 2006 Aug; 97(8):245-55. PubMed ID: 17087362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of asthma in wheezing infants with Chlamydia pneumoniae infection.
    Zaitsu M
    J Asthma; 2007 Sep; 44(7):565-8. PubMed ID: 17885860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.